CILASTATIN FOR USE IN TREATMENT OF SEPSIS

摘要

The present invention relates to the treatment of sepsis and acute kidney injury associated with sepsis (sa-aki). more specifically, it refers to cilastatin for use in a method of treating sepsis and / or sa-aki and reducing its associated mortality in a mammalian subject. It is also directed to methods for treating sepsis and / or sa-aki; and to pharmaceutical compositions for use in the methods of the invention.